The first aim of our study was to compare the gene expression of TRIM28 in a cohort of 95 GB and 19 LGG tumour samples and non-cancerous brain samples, as well as in primary patient-isolated differentiated GB cells vs. their GSC counterparts. This evidence concerns the gene TRIM28 and neoplasm.